Drugs / Anti-CD19 Universal CAR-T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05105867 | Sep 2021 → Aug 2024 | B-cell acute lymphoblastic leukemia | 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-CD19 Universal CAR-T Cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05105867 ↗ |
| Modality | Cell therapy | “CAR-T cell infusion” NCT05105867 ↗ |
| Route | Intravenous | “administered by vein after lymphodepletion” NCT05105867 ↗ |